Joint Reconstruction Devices Market Size By Joint Type (Knee Replacement {Product [Primary Knee Systems, Revision Knee Systems, Partial Knee Systems], Component [Femoral Component, Tibial Component, Patellar Component]}, Hip Replacement {Product [Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, Hip Resurfacing Devices], Component [Acetabular component, Femoral Component]}, Shoulder Replacement {Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Implants, Shoulder Arthroplasty Platform Implants}, Ankle Replacement {Two-Component Fixed Bearing, Three-Component Mobile Bearing}), COVID19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Industry Trends

Joint Reconstruction Devices Market size was valued at around USD 16.8 billion in 2020 and is anticipated to grow at a CAGR of over 5.2% between 2021 and 2027. The increasing prevalence of arthritis and musculoskeletal ailments across the world is fueling the market growth. The rise in the number of orthopedic surgeries is driving the adoption of joint reconstruction devices. Furthermore, an increase in the geriatric population is augmenting the demand for joint reconstruction devices. Rising life expectancy specifically in developing economies is resulting in the surge of more cases related to joint ailments.
 

Get more details on this report - Request Free Sample PDF
 

Joint reconstruction devices are implantable medical devices that are used as a replacement for the shoulder, knee, hip, or ankle joint. These devices provide primary fixation to the bone for the replacement of articulating surface. Joint replacement is the removal of a painful joint and replaces it with an artificial joint. Total joint replacements are permanent implants that involve the removal of extensive bone and cartilage. The design of a prosthesis for joint replacement depends on the dynamic load transfer characteristic of the joint and kinematic.
 

However, joint reconstruction surgery is one of the most successful procedures in orthopedic surgery, post-surgical complications are major concerns after joint replacement procedure. It can have serious issues that may lead to limb fusion or limb loss. The prosthesis used in joint reconstruction surgeries has a susceptibility for attracting bacteria that lead to biofilm formation and colonization. Thus, to prevent post-surgical complications, manufacturers emphasize on the development of smart devices with antimicrobial surfaces to inhibit bacterial attachment.
 

Additionally, risks such as wound infection, blood clotting, malfunction of the prosthesis are involved after the replacement procedures. Soft tissue around the joint can be damaged during the surgery. In rare cases, there is damage to the surrounding arteries, nerves (0.5%), or veins (0.4%) that can cause decreased feeling in the leg or leg weakness. In addition to this, the biocompatibility issues and high cost of joint reconstruction devices will hamper the industry growth.
 

The ongoing COVID-19 pandemic is an unprecedented public health concern and has adversely impacted various joint reconstruction surgical procedures. High risk involved during surgical procedures, owing to coronavirus infection with rising patient invasion in the hospitals is the key factor contributing to a decrease in surgical procedures. Although, the joint reconstruction devices market is expected to witness significant growth attributed to the decreasing number of COVID-19 patients in some regions and the implementation of standard operating protocols in healthcare settings. The government campaign for delivering clinical emergency care to patients suffering from osteoarthritis has sustained the industry demand.
 

Rise in the number of joint reconstruction surgeries in North America is predicted to propel the market expansion

Increase in the number of joint reconstruction surgeries in North America will promote the joint reconstruction devices market progression. Joint reconstruction surgery is a medical procedure that comprises the repair of a damaged joint to provide permanent solutions to joint ailments. According to the American Academy of Orthopedic Surgeons, the number of primary total knee replacements is set to reach around 1.28 million by 2030.  For instance, as per the recent data published by the Center for Orthopedic & Neurological Care, in the U.S., more than a million knee and hip replacement surgeries are performed. These growing number of joint reconstruction surgeries will boost the market revenue. The surge in the number of road accidents often requires joint replacement surgery and is poised to amplify the market for joint reconstruction devices in the region. The Hospital for Special Surgery (HSS) in the U.S. received a USD 10 million grant from Stavros Niarchos Foundation, engaged in providing research, diagnosis, and treatments in joint reconstruction disorders.  
 

In Canada, the number of joint replacements has increased over the past few years with over 137,000 surgeries performed annually. Knee and hip replacements are the third and second most common surgeries performed in Canada. For instance, over 62,000 hip reconstructions and 75,000 knee reconstructions were conducted in Canada in 2018–2019. The Canadian Joint Replacement Registry monitor outcomes of joint reconstruction surgeries and understand factors that affect outcomes of these procedures.
 

In Canada, patients suffering from degenerative arthritis are increasing led by a surge in the aging population along with critical injuries due to a fall and likely incidents. The Canadian Institute for Health Information emphasizes on expanding its findings on joint replacement surgery and deliver effective health care services. Further, few hospitals in Canada offer joint replacement surgery on same day with a rapid recovery plan and a special application to monitor patients at home.
 

Recent technological advancements in the European countries will foster the joint reconstruction devices market demand

Increase in demand for novel implants and the long-term life span of joint reconstruction devices will enhance the industry expansion in the European region. Orthopedic prostheses account for the widely used joint reconstruction devices in Europe. Over the past few years improved technological advancements and rising awareness related to joint disorders drive the surging demand for orthopedic treatments in the region. Continuous technological advancements in the joint reconstruction devices, improvements in design, and effectiveness have enabled the convenience of these devices. Extensive research and improvements in the implants used for knee, hip, shoulder, and ankle replacement have introduced advanced joint reconstruction devices in the market such as 3D printed, patient-specific, and customized implants, etc. Innovative technologies along with robotics are being used in business operations that will further stimulate the industry revenue.
 

Moreover, players in the region are engaged in funding research activities in surgical robotics to offer direction during surgeries or to get 3D scans that aid in the design of customized joint replacement devices. Technological advancements including motion preservation techniques, minimally invasive surgeries, and tissue-guided surgeries among others are improving various surgical procedures, thereby boosting the industry progression.
 

The European Knee Society is actively engaged in partnerships with leaders in the area of knee arthroplasty and degenerative knee pathology. This association intended to promote better-quality treatments for arthroplasty and degenerative ailments of the knee. The European Federation of National Associations of Orthopedics and Traumatology aims to promote research in the field of prevention and surgical treatment of injuries concerning the musculoskeletal system. The Orthopedic Data Evaluation Panel in Europe provides ratings for shoulder, hip, and knee prostheses produced by manufacturers to aid surgeons recognize joint reconstruction devices at risk of premature failure.  
 

Growing usage of knee joint reconstruction devices will spur the market growth

Get more details on this report - Request Free Sample PDF

The knee replacement segment in the joint reconstruction devices market accounted for more than USD 7.8 billion in 2020 owing to the increasing prevalence of disorders associated with knees amongst the geriatric population due to the weakening of bones. The rising prevalence of osteoarthritis in the elderly population within the age group of 65 years and above has influenced the demand for knee replacement products.  The segment growth is further credited to the increasing demand for knee replacement surgeries that are more frequent in Germany as compared to other countries globally. The rate of knee replacement procedures in Germany is around 207 per 100,000 populations with the majority of the people in the age group of 50 years and above that has stimulated the market progression. In addition to this, the development of medical tourism in Europe has facilitated the improvement of knee replacement procedures.
 

According to the Centers for Disease Control and Prevention, in the U.S., currently there are over 2.6 million people affected by osteoporosis that is rising the demand for knee replacement products. Major companies operating in the joint reconstruction devices market such as Stryker and Zimmer Biomet have undertaken certain initiatives to implement improvisations in the joint reconstruction devices that are utilized in the knee replacement procedures. Around 85%-90% of the total implants work well up to 20-25 years hence, increasing preference for such better-quality implants is impelling the joint replacement devices demand. Companies such as Smith & Nephew plc and, Aesculap, Inc. have developed implant technology that addresses metal sensitivity issues associated with joint replacement devices. Therefore, increased level of technological advancements pertaining to knee implants will directly impact the industry demand positively.
 

High usage of technologically advanced products in North America will enhance the regional growth

Get more details on this report - Request Free Sample PDF

U.S. dominated the North America joint reconstruction devices market and captured over 94% of the revenue share in 2020 on account of the well-developed healthcare infrastructure and increase in a number of joint reconstruction surgeries. In the U.S., over 900,000 people undergo knee replacement surgical procedures each year attributed to the presence of high-quality joint replacement devices and painless surgeries due to the availability of high precision instruments.
 

Germany held the largest revenue share in the Europe joint reconstruction devices market and exceeded USD 840 million in 2020. The significant market share is attributed to the focus on health, health sector-related R&D, and innovation. The development of new alloys and bio-based material enables further enhancement of joint replacement devices and medical implants. Around 2 million people in Europe are diagnosed with rheumatoid arthritis and over 3.76 million people in Germany have prescribed treatment for various types of surgeries including joint reconstruction surgeries. The government of Germany has initiated certain policies that have increased the preference for joint replacement procedures by the geriatric population, helping in relieving the pain.
 

Strategic initiatives implemented by major industry players will augment the market value

Some of the major companies operating in the joint reconstruction devices market are Stryker, Medtronic, Zimmer Biomet, DJO Global, ConforMIS, Smith & Nephew, NuVasive, MicroPort Scientific Corporation, Globus Medical, Medacta, and Waldemar LINK among others. These participants are engaged in strategic acquisitions, mergers, collaborations, partnerships, expansions, and product launches among other strategies to maintain a competitive edge. These industry leaders also focus on research and development activities that enable garnering the maximum revenue share.
 

Recent industry developments:

• In July 2019, Microport Scientific Corporation launched the Evolution NitrX Medial-Pivot Knee System. This strategic move aided company in increasing its customer base and further assisted in revenue generation.
   
• In November 2018, Medacta received U.S. FDA approval for GMK sphere – surgical system and kinematic alignment instrumentation. These alignment options are intended for use in total knee replacement procedure. This approval supported the company to broaden its product portfolio and strengthen its market presence.
   

Joint reconstruction devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Joint Type, 2016 - 2027 (USD Million)

• Knee Replacement
  • Product
    • Primary Knee Systems
    • Revision Knee Systems
    • Partial Knee Systems
  • Component
    • Femoral Component
    • Tibial Component
    • Patellar Component
• Hip Replacement
  • Product
    • Primary Hip Reconstruction Devices
    • Partial Hip Reconstruction Devices
    • Revision Hip Reconstruction Devices
    • Hip Resurfacing Devices
  • Component
    • Acetabular component
    • Femoral Component
• Shoulder Replacement
  • Shoulder Arthroplasty Resurfacing Implants
  • Shoulder Arthroplasty Trauma Implants
  • Shoulder Arthroplasty Platform Implants
• Ankle Replacement
  • Two-Component Fixed Bearing
  • Three-Component Mobile Bearing

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE